Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Scott T. Rottinghaus files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jay R. Luly - $67K of ENTA open-market activity in the last 12 months
- Yat Sun Or - $34K of ENTA open-market activity in the last 12 months
- Tara Lynn Kieffer - $30K of ENTA open-market activity in the last 12 months
- Brendan Luu - $20K of ENTA open-market activity in the last 12 months
- Harry R. Trout III - $13K of ENTA open-market activity in the last 12 months
- Kathleen S. Capps - $7K of ENTA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Scott T. Rottinghaus?
Scott T. Rottinghaus is a corporate insider, tracked as Chief Medical Officer of ENANTA PHARMACEUTICALS INC (ENTA). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Scott T. Rottinghaus submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Scott T. Rottinghaus been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($18K) across all tracked filings.
Where can I see all of Scott T. Rottinghaus's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Scott T. Rottinghaus and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
